|
CN112195148A
|
|
Serum-free suspension-adapted MDCK cell and application thereof in preparation of influenza virus vaccine
|
|
WO2021062961A1
|
|
Application of peg-interferon and protooncogene product targeting inhibitor in synergistic inhibition of tumors
|
|
WO2021062960A1
|
|
Application of peg interferon and proto-oncogene product targeting inhibitor in synergistic treatment of renal carcinoma
|
|
CN109021093A
|
|
Polyethyleneglycol modified GLP-1 derivative and its pharmaceutical salts
|
|
CN110724194A
|
|
anti-HER 3 humanized monoclonal antibody and preparation thereof
|
|
CN108250297A
|
|
Anti-egfr antibodies, its preparation method and its application
|
|
CN108239660A
|
|
A kind of recombination tuberculosis vaccine, preparation method and application
|
|
CN106554949A
|
|
The purification process of the uricase of PEGization
|
|
CN106554948A
|
|
Saltant type uricase, the saltant type uricase of PEG modifications and its application
|
|
CN105582534A
|
|
A gelatin-free varicella vaccine freeze-dried preparation and a preparing method thereof
|
|
CN105367657A
|
|
Anti-HER3 antibody, preparing method thereof and applications of the antibody
|
